A Registry Study of NanoKnife IRE for Stage 3 Pancreatic Cancer

NCT03899649 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

532

Enrollment

INDUSTRY

Sponsor class

Conditions

Stage III Pancreatic Cancer

Interventions

DRUG: SOC
DEVICE: NanoKnife System

Sponsor

Angiodynamics, Inc.